肺炎链球菌（Streptococcus pneumoniae）引发的疾病危害大，耐药菌株增加治疗难度，新抗菌药相关研究少。研究人员开展多中心研究，分析 208 株菌株。结果显示新抗生素耐药率低，明确了耐药机制。这为临床治疗和疫苗研发提供依据。

Acurx Pharmaceuticals (Nasdaq: ACXP) (Acurx or the Company), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...

When people hear the word "common cold" or "flu", they usually dismiss it as a harmless, everyday illness — something that's ...